Annual Congress of the European Association of Nuclear Medicine, October 4–8, 2025 | Barcelona, Spain
Rationale 1.Is PSMA-TRT beneficial in the treatment of OSCC in monotherapy? combined with ICI? 2. Do these benefits differ between ... single high-activity TRT administration (SD-TRT); fractionated-activity TRT administration (FX-TRT)? Undefined (> 90 days) * Compared to control (Mantel-Cox log rank test, p < 0.05) ** Compared to control and SD-TRT (Mantel-Cox log rank test, p < 0.05)
Publication Details
- Journal
- EANM Innovation
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/s3051-2913(25)00004-7
- Citations
- 2
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- Universitair Ziekenhuis Gent
- Universiteit Gent
- Kom op tegen Kanker
- Stand Up To Cancer